As leaders across the United States consider options to reduce healthcare costs, they must ensure that well-intended reforms ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?

Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of ...

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...

The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug ...

The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

The rapid emergence and re-emergence of viral pathogens—exemplified by outbreaks of influenza, Ebola, Zika, and, most recently, SARS-CoV-2—underscore the ...

Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...

President Donald Trump's proposed budget cuts to the National Institutes of Health would eventually result in fewer drugs on ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...